Live Breaking News & Updates on Mthera Pharma Co Ltd

Stay updated with breaking news from Mthera pharma co ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

DA-1726 Phase 1 IND Filing Expected by Year End 2023
Board Strengthened with Recent Appointment of Industry Veteran, James P. Tursi, M.D.
Cash and Cash Equivalents of $25.8 Million, Expected to Fund. ....

United States , Marshall Woodworth , Michael Miller , Zeid Kayali , Jamesp Tursi , David Ramirez , Fund The Company Into Fourth Quarter , Neurobo Pharmaceuticals , Drug Administration , Empire Liver Foundation , Board Nominating Committee , Development Rd Expenses , Mthera Pharma Co Ltd , Neurobo Pharmaceuticals Inc , Rx Communications Group , Donga St Co , Year End , Recent Appointment , Industry Veteran , Cash Equivalents , Company Into , Fourth Quarter , Through Multiple Potential Value Creating , Hyung Heon Kim , Chief Executive Officer , Institutional Review Board ,

NeuroBo Pharmaceuticals Enters Into Term Sheet With MThera Pharma to Out-license NB-01

/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today. ....

United States , South Korea , Soult Ukpyolsi , Michael Miller , Mthera Pharma , Joseph Hooker , Drug Administration , Neurobo Pharmaceuticals Inc , Neurobo Pharmaceuticals , Prnewswire Neurobo Pharmaceuticals Inc , Rx Communications Group , Mthera Pharma Co Ltd , Exchange Commission On , Securities Exchange , Interim President , Chief Executive Officer , Non Alcoholic Steatohepatitis , G Protein Coupled Receptor , Private Securities Litigation Reform Act , Securities Exchange Act , Annual Report , Exchange Commission ,